Claudia Cellini

4.4k total citations
30 papers, 1.6k citations indexed

About

Claudia Cellini is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Claudia Cellini has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Claudia Cellini's work include Multiple Myeloma Research and Treatments (20 papers), Cancer Treatment and Pharmacology (9 papers) and Protein Degradation and Inhibitors (9 papers). Claudia Cellini is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Cancer Treatment and Pharmacology (9 papers) and Protein Degradation and Inhibitors (9 papers). Claudia Cellini collaborates with scholars based in Italy and United States. Claudia Cellini's co-authors include S Tura, Michele Baccarani, Patrizia Tosi, Michèle Cavo, Elena Zamagni, Delia Cangini, Paola Tacchetti, Antonio De Vivo, Nicoletta Testoni and Giulia Perrone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Claudia Cellini

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Cellini Italy	20	1.2k	862	813	286	271	30	1.6k
Laurent Voillat France	20	1.9k 1.7×	1.4k 1.6×	1.3k 1.6×	380 1.3×	261 1.0×	47	2.4k
K.R. Desikan United States	18	1.6k 1.4×	997 1.2×	787 1.0×	120 0.4×	245 0.9×	31	1.9k
Darrell White Canada	23	1.3k 1.1×	998 1.2×	1.0k 1.2×	456 1.6×	311 1.1×	134	1.9k
Miguel‐Teodoro Hernández Spain	14	796 0.7×	597 0.7×	544 0.7×	165 0.6×	210 0.8×	44	1.2k
Kamel Laribi France	17	604 0.5×	336 0.4×	606 0.7×	329 1.2×	321 1.2×	62	1.2k
Janice M. Hodnefield United States	18	1.3k 1.1×	727 0.8×	379 0.5×	356 1.2×	763 2.8×	28	1.7k
Delia Cangini Italy	15	1.4k 1.2×	922 1.1×	960 1.2×	77 0.3×	203 0.7×	32	1.7k
Patrizia Pregno Italy	18	989 0.8×	607 0.7×	710 0.9×	690 2.4×	384 1.4×	74	1.8k
Aurore Perrot France	20	847 0.7×	626 0.7×	553 0.7×	147 0.5×	244 0.9×	130	1.2k
Nikolaos Anagnostopoulos Greece	17	753 0.6×	513 0.6×	474 0.6×	456 1.6×	576 2.1×	41	1.3k

Countries citing papers authored by Claudia Cellini

Since Specialization

Citations

This map shows the geographic impact of Claudia Cellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Cellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Cellini more than expected).

Fields of papers citing papers by Claudia Cellini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Cellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Cellini. The network helps show where Claudia Cellini may publish in the future.

Co-authorship network of co-authors of Claudia Cellini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Cellini. A scholar is included among the top collaborators of Claudia Cellini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Cellini. Claudia Cellini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zannetti, Beatrice Anna, Francesco Saraceni, Claudia Cellini, et al.. (2021). Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study. Transplantation and Cellular Therapy. 27(3). 244.e1–244.e8. 20 indexed citations

Mina, Roberto, Alessandra Larocca, Massimo Offidani, et al.. (2020). Efficacy and Safety of Ixazomib Induction and Maintenance in Newly Diagnosed Multiple Myeloma Patients According to the IMWG Frailty Score: A Post-Hoc Analysis of the EMN10-Unito Trial. Blood. 136(Supplement 1). 44–45. 4 indexed citations

Pellegrini, Cinzia, Beatrice Casadei, Claudia Cellini, et al.. (2018). Sequential Double Bridging to Transplant with Diversified Anti- PD1 Monoclonal Antibodies Retreatment in Relapsed Hodgkin Lymphoma: A Case Report. Journal of Cancer Science & Therapy. 10(6). 1 indexed citations

Zannetti, Beatrice Anna, Paola Tacchetti, Lucia Pantani, et al.. (2017). Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma. Annals of Hematology. 96(12). 2071–2078. 3 indexed citations

Curti, Antonio, Patrizia Tosi, Patrizia Comoli, et al.. (2007). Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient‐specific tumour idiotype protein or idiotype (VDJ)‐derived class I‐restricted peptides. British Journal of Haematology. 139(3). 415–424. 53 indexed citations

Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2006). First‐line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. European Journal Of Haematology. 76(5). 399–404. 42 indexed citations

Cavo, Michèle, Elena Zamagni, Patrizia Tosi, et al.. (2005). Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood. 106(1). 35–39. 258 indexed citations

Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2005). Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma. European Journal Of Haematology. 74(3). 212–216. 74 indexed citations

Cavo, Michèle, Elena Zamagni, Patrizia Tosi, et al.. (2004). First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 89(7). 826–31. 146 indexed citations

10.

Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2004). Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. European Journal Of Haematology. 73(2). 98–103. 89 indexed citations

11.

Curti, Antonio, Alessandro Isidori, Elisa Ferri, et al.. (2004). Generation of Dendritic Cells from Positively Selected CD14⁺Monocytes for Anti-tumor Immunotherapy. Leukemia & lymphoma. 45(7). 1419–1428. 22 indexed citations

12.

Cavo, Michèle, Paola Tacchetti, Elena Zamagni, et al.. (2004). Superiority of First-Line Thalidomide-Dexamethasone over Vincristine-Doxorubicin-Dexamethasone in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.. Blood. 104(11). 1489–1489. 12 indexed citations

13.

Motta, Maria Rosa, Simonetta Rizzi, Antonio Curti, et al.. (2003). Generation of dendritic cells from CD14⁺ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti‐idiotype vaccination. British Journal of Haematology. 121(2). 240–250. 38 indexed citations

14.

Tosi, P., Elena Zamagni, Claudia Cellini, et al.. (2002). Salvage Therapy With Thalidomide In Patients With Advanced Relapsed/Refractory Multiple Myeloma. Journal of the Peripheral Nervous System. 7(3). 209–209. 8 indexed citations

15.

Tosi, Patrizia, Sonia Ronconi, Elena Zamagni, et al.. (2001). Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.. PubMed. 86(4). 409–13. 26 indexed citations

16.

Tosi, Patrizia, Sonia Ronconi, Elena Zamagni, et al.. (2000). Salvage therapy with thalidomide for patients with advanced relapsed/refractory multiple myeloma. Blood. 96. 6 indexed citations

17.

Zinzani, Pier Luigi, Massimo Magagnoli, Maurizio Bendandi, et al.. (2000). Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas. Annals of Oncology. 11(3). 363–366. 35 indexed citations

18.

Zinzani, Pier Luigi, Massimo Magagnoli, Franca Chierichetti, et al.. (1999). The role of positron emission tomography (PET) in the management of lymphoma patients. Annals of Oncology. 10(10). 1181–1184. 136 indexed citations

19.

Zinzani, Pier Luigi, Maurizio Martelli, Massimo Magagnoli, et al.. (1999). How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?. PubMed. 84(11). 996–1001. 8 indexed citations

20.

Zinzani, Pier Luigi, Massimo Magagnoli, Luciano Moretti, et al.. (1999). Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.. PubMed. 84(11). 1002–6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact